1. Zhang, Nannan, Yu, Hao, Liu, Tianzi, Hou, Xiaofeng, Zou, Jiangang. 2023. Bmal1 downregulation leads to diabetic cardiomyopathy by promoting Bcl2/IP3R-mediated mitochondrial Ca2+ overload. In Redox biology, 64, 102788. doi:10.1016/j.redox.2023.102788. https://pubmed.ncbi.nlm.nih.gov/37356134/
2. Loo, Jia Min, Scherl, Alexis, Nguyen, Alexander, Paty, Philip B, Tavazoie, Sohail F. 2015. Extracellular metabolic energetics can promote cancer progression. In Cell, 160, 393-406. doi:10.1016/j.cell.2014.12.018. https://pubmed.ncbi.nlm.nih.gov/25601461/
3. Zhou, Fengxin, Dou, Xinli, Li, Chenguang. 2022. CKB affects human osteosarcoma progression by regulating the p53 pathway. In American journal of cancer research, 12, 4652-4665. doi:. https://pubmed.ncbi.nlm.nih.gov/36381321/
4. Rahbani, Janane F, Scholtes, Charlotte, Lagarde, Damien M, Giguère, Vincent, Kazak, Lawrence. 2022. ADRA1A-Gαq signalling potentiates adipocyte thermogenesis through CKB and TNAP. In Nature metabolism, 4, 1459-1473. doi:10.1038/s42255-022-00667-w. https://pubmed.ncbi.nlm.nih.gov/36344764/
5. Wang, Zheng, Hulsurkar, Mohit, Zhuo, Lijuan, Gleave, Martin E, Li, Wenliang. 2021. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation. In Neoplasia (New York, N.Y.), 23, 1147-1165. doi:10.1016/j.neo.2021.09.005. https://pubmed.ncbi.nlm.nih.gov/34706306/
6. Luo, Yuanyuan, Zhang, Lingxiao, Zhao, Tongfeng. 2023. Identification and analysis of cellular senescence-associated signatures in diabetic kidney disease by integrated bioinformatics analysis and machine learning. In Frontiers in endocrinology, 14, 1193228. doi:10.3389/fendo.2023.1193228. https://pubmed.ncbi.nlm.nih.gov/37396184/
7. Mishima, Eikan, Conrad, Marcus. . Nonmetabolic role for CKB in ferroptosis. In Nature cell biology, 25, 633-634. doi:10.1038/s41556-023-01104-0. https://pubmed.ncbi.nlm.nih.gov/37156911/
智鼠故事 
